Involvement of yes-associated protein 1 activation in the matrix degradation of human-induced-pluripotent-stem-cell-derived chondrocytes induced by T-2 toxin and deoxynivalenol alone and in combinationVisa övriga samt affilieringar
2024 (Engelska)Ingår i: International Journal of Molecular Sciences, ISSN 1661-6596, E-ISSN 1422-0067, Vol. 25, nr 2, artikel-id 878
Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
T-2 toxin and deoxynivalenol (DON) are two prevalent mycotoxins that cause cartilage damage in Kashin-Beck disease (KBD). Cartilage extracellular matrix (ECM) degradation in chondrocytes is a significant pathological feature of KBD. It has been shown that the Hippo pathway is involved in cartilage ECM degradation. This study aimed to examine the effect of YAP, a major regulator of the Hippo pathway, on the ECM degradation in the hiPS-derived chondrocytes (hiPS-Ch) model of KBD. The hiPS-Ch injury models were established via treatment with T-2 toxin/DON alone or in combination. We found that T-2 toxin and DON inhibited the proliferation of hiPS-Ch in a dose-dependent manner; significantly increased the levels of YAP, SOX9, and MMP13; and decreased the levels of COL2A1 and ACAN (all p values < 0.05). Immunofluorescence revealed that YAP was primarily located in the nuclei of hiPS-Ch, and its expression level increased with toxin concentrations. The inhibition of YAP resulted in the dysregulated expression of chondrogenic markers (all p values < 0.05). These findings suggest that T-2 toxin and DON may inhibit the proliferation of, and induce the ECM degradation, of hiPS-Ch mediated by YAP, providing further insight into the cellular and molecular mechanisms contributing to cartilage damage caused by toxins.
Ort, förlag, år, upplaga, sidor
MDPI, 2024. Vol. 25, nr 2, artikel-id 878
Nyckelord [en]
Deoxynivalenol, Kashin–Beck disease, T-2 toxin, YAP, hiPSCs
Nationell ämneskategori
Cell- och molekylärbiologi Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) Cellbiologi
Forskningsämne
cellforskning; medicinsk cellbiologi; toxikologi
Identifikatorer
URN: urn:nbn:se:umu:diva-219960DOI: 10.3390/ijms25020878ISI: 001152922800001PubMedID: 38255951Scopus ID: 2-s2.0-85183253930OAI: oai:DiVA.org:umu-219960DiVA, id: diva2:1831330
2024-01-252024-01-252024-03-18Bibliografiskt granskad